Skip to main content
Livermore
Livermore
ZHEN

Pasadena Private Wealth, LLC

SEC CIK
0001760578
Latest filing
Aug 10, 2026

HBIO holding history

Harvard Bioscience Inc in every 13F filed by Pasadena Private Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HBIO overviewAll 13F holders of HBIOFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of HBIO by Pasadena Private Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−4,500−100.0%Sold outConverted for a 1-for-10 splitHolders
Q4 202545,000$30.1K<0.1%−198,911−81.6%ReducedHolders
Q3 2025243,911$107.0K<0.1%00.0%UnchangedHolders
Q2 2025243,911$108.2K<0.1%+45,872+23.2%AddedHolders
Q1 2025198,039$112.1K<0.1%00.0%UnchangedHolders
Q4 2024198,039$417.9K0.1%00.0%UnchangedHolders
Q3 2024198,039$532.7K0.1%00.0%UnchangedHolders
Q2 2024198,039$564.4K0.1%+25,554+14.8%AddedHolders
Q1 2024172,485$731.3K0.2%00.0%UnchangedHolders
Q4 2023172,485$922.8K0.2%00.0%UnchangedHolders
Q3 2023172,485$741.7K0.2%00.0%UnchangedHolders
Q2 2023172,485$946.9K0.3%+38,259+28.5%AddedHolders
Q1 2023134,226$563.7K0.2%00.0%UnchangedHolders
Q4 2022134,226$371.8K0.1%00.0%UnchangedHolders
Q3 2022134,226$344.0K0.1%00.0%UnchangedHolders
Q2 2022134,226$483.0K0.2%+16,925+14.4%AddedHolders
Q1 2022117,301$728.0K0.2%+1,401+1.2%AddedHolders
Q4 2021115,900$817.0K0.3%+8,150+7.6%AddedHolders
Q3 2021107,750$752.0K0.3%+4,075+3.9%AddedHolders
Q2 2021103,675$864.0K0.3%+32,175+45.0%AddedHolders
Q1 202171,500$390.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.